XML 18 R7.htm IDEA: XBRL DOCUMENT v3.24.2.u1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Paid-in Capital
Retained Earnings
Accumulated Other Comprehensive Loss
Treasury Stock
Nonredeemable Noncontrolling Interests
Beginning balance (in shares) at Jan. 28, 2023   54,609,786          
Beginning balance gain (loss) at Jan. 28, 2023 $ 572,751 $ 546 $ 532,398 $ 1,276,857 $ (134,073) $ (1,141,615) $ 38,638
Beginning balance (in shares) at Jan. 28, 2023           88,161,467  
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net earnings (loss) (10,694)     (11,805)     1,111
Other comprehensive income (loss), net of income tax benefit (4,095)       (5,404)   1,309
Issuance of common stock under stock compensation plan (in shares)   1,085,319       1,085,319  
Issuance of common stock under stock compensation plan (450) $ 11 (14,519)     $ 14,058  
Issuance of stock under Employee Stock Purchase Plan (in shares)   11,848       11,848  
Issuance of stock under Employee Stock Purchase Plan 181   28     $ 153  
Share-based compensation 4,620   4,617 3      
Dividends (12,662)     (12,662)      
Share repurchases (in shares)   (2,237,872)       (2,237,872)  
Share repurchases (42,821) $ (22) 22     $ (42,821)  
Equity component value of convertible notes transactions, net (744)   (744)        
Sale of common stock warrants 20,158   20,158        
Purchase of convertible note hedges (39,397)   (39,397)        
Termination of common stock warrants (1,024)   (1,024)        
Termination of convertible note hedges 7,235   7,235        
Ending balance (in shares) at Apr. 29, 2023   53,469,081          
Ending balance gain (loss) at Apr. 29, 2023 493,058 $ 535 508,774 1,252,393 (139,477) $ (1,170,225) 41,058
Ending balance (in shares) at Apr. 29, 2023           89,302,172  
Beginning balance (in shares) at Jan. 28, 2023   54,609,786          
Beginning balance gain (loss) at Jan. 28, 2023 572,751 $ 546 532,398 1,276,857 (134,073) $ (1,141,615) 38,638
Beginning balance (in shares) at Jan. 28, 2023           88,161,467  
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net earnings (loss) 31,268            
Other comprehensive income (loss), net of income tax benefit         1,516    
Ending balance (in shares) at Jul. 29, 2023   53,587,282          
Ending balance gain (loss) at Jul. 29, 2023 533,821 $ 536 514,760 1,274,835 (132,557) $ (1,168,677) 44,924
Ending balance (in shares) at Jul. 29, 2023           89,183,971  
Beginning balance (in shares) at Apr. 29, 2023   53,469,081          
Beginning balance gain (loss) at Apr. 29, 2023 493,058 $ 535 508,774 1,252,393 (139,477) $ (1,170,225) 41,058
Beginning balance (in shares) at Apr. 29, 2023           89,302,172  
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net earnings (loss) 41,962     39,033     2,929
Other comprehensive income (loss), net of income tax benefit 9,302       6,920   2,382
Issuance of common stock under stock compensation plan (in shares)   107,116       107,116  
Issuance of common stock under stock compensation plan 592 $ 1 (811)     $ 1,402  
Issuance of stock under Employee Stock Purchase Plan (in shares)   11,085       11,085  
Issuance of stock under Employee Stock Purchase Plan 170   24     $ 146  
Share-based compensation 5,455   5,455        
Dividends (16,591)     (16,591)      
Purchase of redeemable noncontrolling interest 95   1,318       (1,223)
Noncontrolling interest capital distribution (222)           (222)
Ending balance (in shares) at Jul. 29, 2023   53,587,282          
Ending balance gain (loss) at Jul. 29, 2023 $ 533,821 $ 536 514,760 1,274,835 (132,557) $ (1,168,677) 44,924
Ending balance (in shares) at Jul. 29, 2023           89,183,971  
Beginning balance (in shares) at Feb. 03, 2024 53,007,966 53,007,966          
Beginning balance gain (loss) at Feb. 03, 2024 $ 734,794 $ 530 594,520 1,412,426 (137,010) $ (1,185,526) 49,854
Beginning balance (in shares) at Feb. 03, 2024 89,763,349         89,763,349  
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net earnings (loss) $ 15,906     13,022     2,884
Other comprehensive income (loss), net of income tax benefit 599       (38)   637
Issuance of common stock under stock compensation plan (in shares)   779,872       779,934  
Issuance of common stock under stock compensation plan 5,649 $ 8 (4,682)     $ 10,323  
Issuance of stock under Employee Stock Purchase Plan (in shares)   9,740       9,740  
Issuance of stock under Employee Stock Purchase Plan 198   69     $ 129  
Share-based compensation 3,120   3,115 5      
Dividends (135,512)     (135,512)      
Share repurchases (in shares)   (326,429)       (326,429)  
Share repurchases (10,279) $ (3) 3     $ (10,279)  
Noncontrolling interest capital distribution (11,735)           (11,735)
Noncontrolling interest capital contribution 219           219
Sale of common stock warrants 3,665   3,665        
Termination of common stock warrants (548)   (548)        
Termination of convertible note hedges 1,044   1,044        
Settlement of convertible senior notes (in shares)   122,313       (122,313)  
Settlement of convertible senior notes 212 $ 1 (1,413)     $ 1,624  
Exercise of convertible notes hedges (in shares)   (90,729)       90,729  
Exercise of convertible notes hedges 0 $ (1) 2,558     $ (2,557)  
Ending balance (in shares) at May. 04, 2024   53,502,733          
Ending balance gain (loss) at May. 04, 2024 $ 607,332 $ 535 598,331 1,289,941 (137,048) $ (1,186,286) 41,859
Ending balance (in shares) at May. 04, 2024           89,268,520  
Beginning balance (in shares) at Feb. 03, 2024 53,007,966 53,007,966          
Beginning balance gain (loss) at Feb. 03, 2024 $ 734,794 $ 530 594,520 1,412,426 (137,010) $ (1,185,526) 49,854
Beginning balance (in shares) at Feb. 03, 2024 89,763,349         89,763,349  
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net earnings (loss) $ 7,270            
Other comprehensive income (loss), net of income tax benefit         (648)    
Ending balance (in shares) at Aug. 03, 2024 51,418,318 51,418,318          
Ending balance gain (loss) at Aug. 03, 2024 $ 531,643 $ 514 599,899 1,262,730 (137,658) $ (1,234,275) 40,433
Ending balance (in shares) at Aug. 03, 2024 91,352,935         91,352,935  
Beginning balance (in shares) at May. 04, 2024   53,502,733          
Beginning balance gain (loss) at May. 04, 2024 $ 607,332 $ 535 598,331 1,289,941 (137,048) $ (1,186,286) 41,859
Beginning balance (in shares) at May. 04, 2024           89,268,520  
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net earnings (loss) (8,636)     (10,603)     1,967
Other comprehensive income (loss), net of income tax benefit (4,003)       (610)   (3,393)
Issuance of common stock under stock compensation plan (in shares)   178,893       178,893  
Issuance of common stock under stock compensation plan (14) $ 2 (2,394)     $ 2,378  
Issuance of stock under Employee Stock Purchase Plan (in shares)   10,832       10,832  
Issuance of stock under Employee Stock Purchase Plan 188   44     $ 144  
Share-based compensation 3,925   3,895 30      
Dividends (16,638)     (16,638)      
Share repurchases (in shares)   (2,274,140)       (2,274,140)  
Share repurchases $ (50,511) $ (23) 23     $ (50,511)  
Ending balance (in shares) at Aug. 03, 2024 51,418,318 51,418,318          
Ending balance gain (loss) at Aug. 03, 2024 $ 531,643 $ 514 $ 599,899 $ 1,262,730 $ (137,658) $ (1,234,275) $ 40,433
Ending balance (in shares) at Aug. 03, 2024 91,352,935         91,352,935